General
Preferred name
LY311727
Synonyms
LY 311727 ()
LY-311727 ()
P&D ID
PD017563
CAS
164083-84-5
Tags
available
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION LY-311727 is a potent secretory non-pancreatic phospholipase A2 (sPLA2) inhibitor (IC50 <1 ¦ÌM for group IIA sPLA2). sPLA2 is an important proinflammatory enzyme[1][2].
DESCRIPTION LY311727 is an inhibitor of Group IIA sPLA2 (IC50 = 0.47 µM). LY311727 inhibited sPLA2-induced platelet aggregation. (BOC Sciences Bioactive Compounds)
Compound Sets
6
BOC Sciences Bioactive Compounds
3-3-2-amino-2-oxoethyl-2-ethyl-1-phenylmethyl-1h-indol-5-yl-cas-164083-84-5-item-129536
Cayman Chemical Bioactives
17973
Drug Repurposing Hub
MedChem Express Bioactive Compound Library
HY-107393
ReFrame library
ZINC Tool Compounds
ZINC000001543374
External IDs
18
Properties
(calculated by RDKit )
Molecular Weight
430.17
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
3
Rotatable Bonds
10
Ring Count
3
Aromatic Ring Count
3
cLogP
3.23
TPSA
114.78
Fraction CSP3
0.32
Chiral centers
0.0
Largest ring
6.0
QED
0.34
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
Phospholipase inhibitor
Pathway
Metabolic Enzyme/Protease
Target
Phospholipase
Source data